Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) EV/EBITDA
As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a EV/EBITDA of 11.1×. Over the past ten years it has ranged from 3.6× (November 2022) to 40.7× (May 2024); the current reading is higher than 55% of that period. That is in line with the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 10.5× | (40.38%) |
| FY2024 | 17.6× | (48.75%) |
| FY2023 | 34.3× | 352.33% |
| FY2022 | 7.6× | (3.32%) |
| FY2021 | 7.9× | (11.74%) |
| FY2020 | 8.9× | 0.60% |
| FY2019 | 8.8× | 27.14% |
| FY2018 | 7.0× | (48.00%) |
| FY2017 | 13.4× | 72.45% |
| FY2016 | 7.8× | (22.42%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 9.2× | 0.38% |
| Jun 2026 | 9.2× | (10.44%) |
| Mar 2026 | 10.3× | (2.23%) |
| Dec 2025 | 10.5× | (5.98%) |
| 37 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| GKOS Glaukos Corporation compare | n/m |
| SNN Smith & Nephew SNATS, Inc. compare | 6.5× |
| PHG Koninklijke Philips N.V. | 11.1× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 12.1× |
| GEHC GE HealthCare Technologies Inc. compare | 13.2× |
| BSX Boston Scientific Corporation compare | 14.0× |
| STE STERIS plc compare | 15.7× |
| DXCM DexCom, Inc. compare | 21.2× |
| EW Edwards Lifesciences Corporation compare | 34.0× |
| Medical Devices industry median | 11.5× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement